Concepedia

Joseph K. Belanoff

JK

38

Publications

3.1K

Citations

28

H-Index

1986

Active since

Affiliations

Corcept Therapeutics (United States)(Current)

Stanford University

Leiden University Medical Center

Radboud University Nijmegen

Experimental Medicine and Biology Institute

Joseph K. Belanoff is an author at Corcept Therapeutics (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyNeuropharmacologyNeuroscienceSocial SciencesPhysiologyPsychiatryNeurologyPsychopharmacology

Publications per year

1986–2023

38

Publications

38

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.

Bruce N. Cronstein, Richard I. Levin, Joseph K. Belanoff et al. · Journal of Clinical Investigation · 1986 · 418 citations · Full text

Inflammation, Endothelial Cell Pathobiology, Medicinal Chemistry +15

An open label trial of C-1073 (mifepristone) for psychotic major depression*

Joseph K. Belanoff, Anthony J. Rothschild, Frederick Cassidy et al. · Biological Psychiatry · 2002 · 314 citations

Psychiatry, Psychotropic Medication, Psychopharmacology +11

Rapid Reversal of Psychotic Depression Using Mifepristone

Joseph K. Belanoff, Benjamin Flores, Michelle Kalezhan et al. · Journal of Clinical Psychopharmacology · 2001 · 281 citations

Psychiatry, Medicine, Depression +12

Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals

Leandro F. Vendruscolo, David Estey, Vivian Goodell et al. · Journal of Clinical Investigation · 2015 · 217 citations · Full text

Neuropsychology, Substance Use, Psychopharmacology +20

Successful Long-Term Treatment of Refractory Cushing’s Disease with High-Dose Mifepristone (RU 486)

James W. Chu, Dwight F. Matthias, Joseph K. Belanoff et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 189 citations · Full text

Rows per page

1–5 of 38